Newsletter Subject

My Annual Rant on Medicare Drug Pricing

From

empirefinancialresearch.com

Email Address

info@exct.empirefinancialresearch.com

Sent On

Fri, Oct 14, 2022 08:33 PM

Email Preheader Text

If you want to know how broken the health care system is – and how outrageously crazy drug pric

If you want to know how broken the health care system is – and how outrageously crazy drug pricing is – look no further than Medicare drug plans... If you're not 65, I'm sure you'll stop reading – and that's fine. I would, too. This doesn't apply to you. But one day... it will! So […] Not rendering correctly? View this e-mail as a web page [here](. [Empire Financial Daily] My Annual Rant on Medicare Drug Pricing By Herb Greenberg --------------------------------------------------------------- [The Number 1 rebound stock of 2022?]( One of the most talked-about stocks of 2022 is set to take off any day. You can grab shares for less than $5... But likely not for long. [Find out why](. --------------------------------------------------------------- If you want to know how broken the health care system is – and how outrageously crazy drug pricing is – look no further than Medicare drug plans... If you're not 65, I'm sure you'll stop reading – and that's fine. I would, too. This doesn't apply to you. But one day... it will! So if that's you, it still makes sense to read today's essay all the way through to the end. At the risk of sounding like an old man yelling at you to get off my lawn... I rant about this every year on social media and, ever since I've been writing these essays, right here. Fair warning – I'm about to do it again... Since turning 65, at open enrollment every year I go through this absurdly ridiculous exercise of going to MyMedicare.gov and checking out what the very same plan I had one year will be the next. And every year, I'm appalled... and I keep wondering: How do people who don't know what to do – or who are too intimidated by the process – navigate all this? This doesn't get much press because most reporters and editors are too young... But it deserves to be front and center because it's simply so egregious. In the five years I've been on Medicare, the prices for the same half-dozen cocktail of meds I take keep spiraling to levels that sometimes make zero sense, especially since they're all generics. And every year, I find a way around it – or at least to mitigate it through my own cobbled-together hack that I'll share with you in a moment. But doing so takes time and ultimately involves some level of inconvenience. --------------------------------------------------------------- Recommended Link: [Our 87% success rate (demo inside)]( We've developed a system that could make you $1,000s per week, by seeing the exact historical success rate on a unique transaction – BEFORE you put down a penny. Like a $1,000 profit you could've made in five days on Grayscale... $900 in six days on Moody's... $1,000 in 24 hours on Virgin Galactic, and more. [See how this works here](. --------------------------------------------------------------- And before we go further, lest you think I'm a penny pincher... I'm not talking about saving a few dollars, I'm talking about saving – in some cases – hundreds of dollars. As they say, even if you can afford it... it's the principle. Which gets us to what's going on this year... If you're on regular Medicare as I am – not Medicare Advantage – the process starts by going to the MyMedicare site, which to be fair has been improving. Or let's just say, it doesn't have that "government" feel, such as, say, the bare-bones, throwback-to-another-era Treasury Direct site. You put in whatever drugs you take regularly or might get occasionally... and then whatever pharmacies you use, including mail order. The site spits out a bunch of options, all priced from cheapest to most expensive, based on drug prices and premiums under each plan. Like all insurance, the higher the premiums, the lower the drug pricing, and vice versa. Obviously, if you take a cocktail like I do, you focus on drug pricing over the premium, with the goal of finding something that balances out to your advantage. That's where this gets tricky, and why I get so incensed... Last year, like every year until this year, there's always a loss leader in the bunch – one whose prices were considerably cheaper than the other options in the same plan. Last year, it was a local independent pharmacy that I tossed into the mix on a lark, figuring it would be the highest. Turns out, it was the lowest... and by a huge amount. I have no idea why, but I chose it because it made sense. That's typically the way it has been. This year, under that same plan, that cheap local pharmacy became the most expensive... and not by a small amount. Here are the numbers... This year, my annual premium is $367. No complaints. Better yet, the total bill for the cheap local pharmacy, based on the Medicare website, was predicted to be $1,464. That compares with more than $2,000 at Costco (COST), the national chains, and mail order – all within a few dollars of one another. This year? I head over to MyMedicare and... yowza! The premium has dropped by a few dollars, and overall pricing for Costco, CVS (CVS), and mail order were in line... while Rite-Aid (RAD) and that cheap local pharmacy soared. But it was the local pharmacy that made my jaw drop – prices under the same plan as last year skyrocketed by 135%. That's nuts. But it gets nuttier than that... The "cheaper" plans at Costco, CVS, and mail order are in theory cheaper because they're "preferred" vendors, as opposed to the others, which are merely "in network." But even at those preferred vendors, while the overall annual price for my cocktail rose a mere 7%, some of the drugs within that group inexplicably shot higher. Take irbesartan – a medication for blood pressure. It more than tripled to $179 per year from $58 per year. Or metoprolol, a lowly beta blocker I started taking after my heart surgery to keep my heart rate consistent – up 167%. Meanwhile, rosuvastatin, better known as Crestor, fell by half. All of that makes zero sense. Which gets to my hack, if you can call it that... I start by running all my drugs through GoodRx (GDRX), which [I wrote about a year ago]( – back when its stock was nearly 10 times higher than it is today. I started doing it last year, and I also check HealthWarehouse and Mark Cuban's Cost-Plus Drug Company, which have both tended to be slightly higher and somewhat more limited in selection. Here's what I found... The new version of this year's plan would charge me $180 for irbesartan. I checked GoodRx, and it showed that the retail price at Walmart (WMT) is $96 for the year – roughly half the price. Another blood pressure pill I take is eplerenone... I had been paying $212 per year. Under the new plan, it's about $1,000 everywhere. With GoodRx, I can get it at Costco for $236. Another drug used to be $72... but under the new plan, it's $576. Buy it online at GoodRx, and I'd pay $132. You get the picture. There's no rhyme or reason... and it's out of control. It always has been, and I'm guessing it always will be. The drug lobby is simply too powerful. Ditto for pharmacy benefit managers, which are an opaque black box that runs the show. The government's deal to allow Medicare to negotiate drug prices is a good start, but it's limited to only ultimately a few dozen drugs and, realistically, is years off. My suggestion: If you have the time and/or inclination, do the cost comparisons. To me, it's like a puzzle and can be a great – albeit maddening – way to kill a few hours. Of course, if you're like me, don't forget to take your blood pressure meds before you start. As always, feel free to reach out via e-mail by [clicking here](mailto:feedback@empirefinancialresearch.com?subject=Feedback%20for%20Herb). I look forward to hearing from you. Regards, Herb Greenberg October 14, 2022 P.S. Bloomberg reports that inflation – which just hit a 40-year high – "has broadened across the economy, eroding Americans' paychecks and forcing many to rely on savings and credit cards to keep up." In other words, things are getting worse. Investors have nowhere to hide. If you're confused about what to do with your money, I urge you to check out my latest presentation. [Click here to see my full analysis for free](. [Get a 60-day, 100% money-back trial to Empire Real Wealth by clicking here.]( --------------------------------------------------------------- If someone forwarded you this e-mail and you would like to be added to the Empire Financial Daily e-mail list to receive e-mails like this every weekday, simply [sign up here](. © 2022 Empire Financial Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Empire Financial Research, 380 Lexington Ave., 4th Floor, New York, NY 10168 [www.empirefinancialresearch.com.]( You received this e-mail because you are subscribed to Empire Financial Daily. [Unsubscribe from all future e-mails](

Marketing emails from empirefinancialresearch.com

View More
Sent On

07/11/2023

Sent On

06/11/2023

Sent On

04/11/2023

Sent On

03/11/2023

Sent On

02/11/2023

Sent On

01/11/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.